Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Absci (ABSI) Other Non Operating Income: 2020-2025

Historic Other Non Operating Income for Absci (ABSI) over the last 6 years, with Sep 2025 value amounting to $1.6 million.

  • Absci's Other Non Operating Income fell 4.03% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 28.16%. This contributed to the annual value of $6.4 million for FY2024, which is 5.91% up from last year.
  • Per Absci's latest filing, its Other Non Operating Income stood at $1.6 million for Q3 2025, which was up 57.96% from $1.0 million recorded in Q2 2025.
  • Over the past 5 years, Absci's Other Non Operating Income peaked at $2.1 million during Q2 2024, and registered a low of -$28.1 million during Q2 2021.
  • For the 3-year period, Absci's Other Non Operating Income averaged around $1.5 million, with its median value being $1.6 million (2023).
  • Its Other Non Operating Income has fluctuated over the past 5 years, first tumbled by 40,062.86% in 2021, then surged by 1,066.40% in 2023.
  • Absci's Other Non Operating Income (Quarterly) stood at $188,000 in 2021, then spiked by 649.47% to $1.4 million in 2022, then climbed by 2.63% to $1.4 million in 2023, then plummeted by 36.31% to $921,000 in 2024, then fell by 4.03% to $1.6 million in 2025.
  • Its Other Non Operating Income was $1.6 million in Q3 2025, compared to $1.0 million in Q2 2025 and $1.5 million in Q1 2025.